Fabbri, Chiara

Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy

Porcelli, S., Fabbri, C., & Serretti, A. (2012) · European Neuropsychopharmacology

Neurotransmitter Receptor Influence on BehaviorTreatment of Major Depression

Cited by 331

Results of the European Group for the Study of Resistant Depression (GSRD) — basis for further research and clinical practice

Bartova, L., Dold, M., Kautzky, A., Fabbri, C., Spies, M., Serretti, A., Souery, D., Mendlewicz, J., Zohar, J., Montgomery, S., et al. (2019) · The World Journal of Biological Psychiatry

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 152

Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study

Kautzky, A., Dold, M., Bartova, L., Spies, M., Kranz, G. S., Souery, D., Montgomery, S., Mendlewicz, J., Zohar, J., Fabbri, C., et al. (2019) · Acta Psychiatrica Scandinavica

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 148

Genetics of resilience: Implications from genome‐wide association studies and candidate genes of the stress response system in posttraumatic stress disorder and depression

Maul, S., Giegling, I., Fabbri, C., Corponi, F., Serretti, A., & Rujescu, D. (2020) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

Resilience and Mental HealthPosttraumatic Stress Disorder Research

Cited by 125

Pharmacogenetics of antidepressants

Crisafulli, C., Fabbri, C., Porcelli, S., Drago, A., Spina, E., De Ronchi, D., & Serretti, A. (2011) · Frontiers in Pharmacology

Neurotransmitter Receptor Influence on BehaviorTreatment of Major Depression

Cited by 113

Pharmacogenetics of major depressive disorder: top genes and pathways toward clinical applications

Fabbri, C., & Serretti, A. (2015) · Current Psychiatry Reports

Treatment of Major DepressionPharmacogenetics and Drug Metabolism

Cited by 84

Shared genetics among major psychiatric disorders

Serretti, A., & Fabbri, C. (2013) · The Lancet

Genetic Associations and EpidemiologySchizophrenia research and treatment

Cited by 77

Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples

Fabbri, C., Kasper, S., Kautzky, A., Bartova, L., Dold, M., Zohar, J., Souery, D., Montgomery, S., Albani, D., Raimondi, I., et al. (2019) · British Journal of Psychiatry

Treatment of Major DepressionGenetic Associations and Epidemiology

Cited by 61

Clinical application of antidepressant pharmacogenetics: Considerations for the design of future studies

Fabbri, C., & Serretti, A. (2020) · Neuroscience Letters

Pharmacogenetics and Drug MetabolismGenetic Associations and Epidemiology

Cited by 42

Clinical specificity profile for novel rapid acting antidepressant drugs

Scala, M., Fanelli, G., De Ronchi, D., Serretti, A., & Fabbri, C. (2023) · International Clinical Psychopharmacology

Treatment of Major DepressionBipolar Disorder and Treatment

Cited by 41

Social withdrawal as a trans-diagnostic predictor of short-term remission: a meta-analysis of five clinical cohorts

Oliva, V., Fanelli, G., Kasper, S., Zohar, J., Souery, D., Montgomery, S., Albani, D., Forloni, G., Ferentinos, P., Rujescu, D., et al. (2022) · International Clinical Psychopharmacology

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 29

Genetic disposition to inflammation and response to antidepressants in major depressive disorder

Zwicker, A., Fabbri, C., Rietschel, M., Hauser, J., Mors, O., Maier, W., Zobel, A., Farmer, A., Aitchison, K. J., McGuffin, P., et al. (2018) · Journal of Psychiatric Research

Treatment of Major DepressionTryptophan and brain disorders

Cited by 28

Combining psychopharmacotherapy and psychotherapy is not associated with better treatment outcome in major depressive disorder - evidence from the European Group for the Study of Resistant Depression

Bartova, L., Fugger, G., Dold, M., Swoboda, M. M. M., Zohar, J., Mendlewicz, J., Souery, D., Montgomery, S., Fabbri, C., Serretti, A., et al. (2021) · Journal of Psychiatric Research

Treatment of Major DepressionPsychotherapy Techniques and Applications

Cited by 25

The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges

Scala, M., Fabbri, C., Fusar-Poli, P., Di Lorenzo, G., Ferrara, M., Amerio, A., Fusar-Poli, L., Pichiecchio, A., Asteggiano, C., Menchetti, M., et al. (2024) · CNS Spectrums

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 13

Obsessive-Compulsive, Psychotic, and Autism Dimensions Overlap in Real World: A Case Report

Scala, M., Biondi, L., Serretti, A., & Fabbri, C. (2023) · Clinical Neuropharmacology

Obsessive-Compulsive Spectrum DisordersAutism Spectrum Disorder Research

Cited by 7

Growth factor polygenic disposition shapes associations of childhood adversity with gray matter and clinical profiles in depression: A two‐cohort imaging‐genetics study

Cazzella, T., Fortaner‐Uyà, L., Paolini, M., Percaccioli, C., Colombo, F., Venturelli, E., Colombo, C., Zanardi, R., Spadini, S., Lorenzi, C., et al. (2026) · Psychiatry and Clinical Neurosciences

Child Abuse and TraumaGenetic Associations and Epidemiology

Cited by 0